Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...

Generic molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...

The developments came after the government said it was cutting the isolation period required for positive cases while Wales and Northern Ir...

The new drugs, which unlike vaccines can be used to treat patients once they contract coronavirus infection, are expected to be a huge mark...

The MHRA recommended the use of Covid-19 drug molnupiravir as soon as possible following a positive Covid-19 test and within five days of s...

The risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease. MHRA recommended the use of Molnupiravir as s...